MANUFACTURE AND SUPPLY AGREEMENT BETWEENManufacture and Supply Agreement • March 16th, 2007 • Penwest Pharmaceuticals Co • Pharmaceutical preparations • Quebec
EX-10.28 6 d665316dex1028.htm EX-10.28 [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities...Manufacture and Supply Agreement • May 5th, 2020
This MANUFACTURE AND SUPPLY AGREEMENT (“Agreement”) is entered into as of December 16, 2013 (the “Effective Date”) between ACELRX PHARMACEUTICALS, INC., a company organized under the laws of the State of Delaware, United States (“AcelRx”), and having a principal place of business at 575 Chesapeake Drive, Redwood City, CA 94063, United States, and GRÜNENTHAL GMBH, a company organized under the laws of Germany (“Grünenthal”), having its registered office at Zieglerstrasse 6, 52078 Aachen, Germany. AcelRx and Grünenthal may be referred to herein from time to time individually as a “Party,” and collectively as the “Parties”.
EX-10.15 18 a2233286zex-10_15.htm EX-10.15 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions....Manufacture and Supply Agreement • May 5th, 2020 • Delaware
This MANUFACTURE AND SUPPLY AGREEMENT (the “Agreement”) is made as of August 18, 2017 (the “Effective Date”) by and among, on the one hand, OptiNose US, Inc., duly organized and existing under the laws of Delaware and having offices located at 1020 Stony Hill Road, Suite 300, Yardley, PA 19067 (referred to herein as “OptiNose US”), OptiNose UK Ltd. duly organized and existing under the laws of England and having offices located at Hunts Rise, South Marston Park, Wiltshire, SN3 4TG, England (referred to herein as “OptiNose UK”), and OptiNose AS, duly organized and existing under the laws of Norway and having offices located at Gaustadalleen 21 0349 Oslo, Norway (referred to herein as “OptiNose Norway”, and collectively with OptiNose US and OptiNose UK, “OptiNose”), and, on the other hand, Contract Pharmaceuticals Limited Canada, duly organized under the laws of the Province of Ontario and having offices located at 7600 Danbro Crescent, Mississauga, Ontario Canada L5N 6L6 (referred to he
EX-10.1 2 d248992dex101.htm MANUFACTURE AND SUPPLY AGREEMENT [*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the...Manufacture and Supply Agreement • May 5th, 2020
THIS MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”), effective as of May 16, 2011 (the “Effective Date”), is made and entered into by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, USA (“Codexis”), and Lactosan GmbH & Co. KG, a corporation organized and existing under the laws of Austria, having a place of business at Industriestrasse West 5, A-8605 Kapfenberg, Austria (“Company”). Codexis and Company each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
ContractManufacture and Supply Agreement • May 5th, 2020 • Delaware
EX-10.7 5 aeri93018ex107.htm AERI 9.30.2018 EX 10.7 In this document, “[***]” indicates that confidential materials have been redacted from this document and filed separately with the Securities and Exchange Commission. Exhibit 10.7 Manufacture and Supply Agreement This Manufacture and Supply Agreement (the “Agreement”) is entered into and made effective as of this 1st day of January 2018 (the “Effective Date”), by and between:
Amended and Restated Manufacture and Supply AgreementManufacture and Supply Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • Pennsylvania
Confidential Materials omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential portions are marked: [ *** ]
ContractManufacture and Supply Agreement • May 5th, 2020
EX-10.56 3 f55133exv10w56.htm EX-10.56 Exhibit 10.56 [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. MANUFACTURE AND SUPPLY AGREEMENT This MANUFACTURE AND SUPPLY AGREEMENT (“Agreement”) is made and effective as of February 9, 2010 (the “Effective Date”) by and between Alexza Pharmaceuticals, Inc., a Delaware corporation having a place of business at 2091 Stierlin Court, Mountain View, CA 94043 (“Alexza”), and Biovail Laboratories International SRL, a Barbados society with restricted liability having its registered office at Welches, Christ Church, Barbados, WI, BB17154 (“BLS”). Alexza and BLS may be referred to herein from time to time individually as a “Party,” and collectively as the “Parties”. WHEREAS, Alexza has developed and owns certain proprietary rights with respect to AZ-004 (Stacca
EX-10.2 2 a15-18097_1ex10d2.htm EX-10.2 *** TEXT OMITTED AND SUBMITTED SEPARATELY PURSUANT TO CONFIDENTIAL TREATMENT REQUEST MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 5th, 2020 • New York
This MANUFACTURE AND SUPPLY AGREEMENT (“Agreement”) is entered into as of the date of the last signature below (the “Effective Date”) between:
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • November 21st, 2003 • Vendingdata Corp • Miscellaneous manufacturing industries
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • February 2nd, 2011 • Sagent Holding Co. • Pharmaceutical preparations • New Jersey
This Manufacture and Supply Agreement (this “Agreement”) is made and entered into as of December 17, 2007 (the “Effective Date”) by and among A.C.S. Dobfar S.p.a., an Italian corporation, having its principal place of business at Viale Addetta, 4/12 Tribiano 20067 Milan Italy (“DOBFAR” or “SUPPLIER”), WorldGen LLC, a New Jersey Limited Liability Company, having its principal place of business at 120 Route 17 North P.O. Box 1579 Paramus, NJ 07653 USA (“WORLDGEN”), and SAGENT PHARMACEUTICALS, INC., a Wyoming corporation, having its principal place of business at 1901 N. Roselle Road, Schaumburg, IL 60195 (“SAGENT”).
AMENDMENT TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • February 21st, 2024 • Theratechnologies Inc. • Pharmaceutical preparations
WHEREAS Purchaser and Supplier signed a Manufacture and Supply Agreement dated as of December 23, 2009, as amended from time to time (the “MSA”);
RECITALSManufacture and Supply Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • California
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 14th, 2024 • OptiNose, Inc. • Pharmaceutical preparations • Delaware
This MANUFACTURE AND SUPPLY AGREEMENT (the “Agreement”) is made as of December 11, 2020 (the “Effective Date”) by and between OptiNose US, Inc., duly organized and existing under the laws of Delaware and having offices located at 1020 Stony Hill Road, Suite 300, Yardley, PA 19067 (“OptiNose”), and Hikma Pharmaceuticals USA Inc., a Delaware corporation, having offices at 1809 Wilson Road, Columbus, OH 43228 (referred to herein as “Hikma”). OptiNose and Hikma are each a “Party” and together constitute the “Parties” under this Agreement.
156 2 1.2 In order to ensure agreement is reached under 1.1 above as soon as practicable any items that are still in dispute by January 20, 2000 will be escalated to the GM of Celestica and VP Operations of Madge.connect for resolution by January 21,...Manufacture and Supply Agreement • July 12th, 2001 • Madge Networks Nv • Computer peripheral equipment, nec
MANUFACTURE AND SUPPLY AGREEMENT by and between BUTTERFLY NETWORK, INC. and BENCHMARK ELECTRONICS, INC.Manufacture and Supply Agreement • November 27th, 2020 • Longview Acquisition Corp. • Blank checks • New York
This Manufacture and Supply Agreement (this “Agreement”), effective as of October 1, 2015 (the “Effective Date”), is by and between BUTTERFLY NETWORK, INC., a Delaware corporation having a place of business at 530 Old Whitfield Street, Guilford, Connecticut 06437 (“Butterfly”), and BENCHMARK ELECTRONICS, INC., a corporation organized under the laws of the State of Texas USA having a place of business at 100 Innovative Way, Nashua, NH 03062 (“Manufacturer”). Butterfly and Manufacturer may be referred to individually as a “Party” and collectively as the “Parties.”
DateManufacture and Supply Agreement • February 28th, 2024
FIRST AMENDMENT AND WAIVER MANUFACTURE AND SUPPLY AGREEMENT EFFECTIVE FEBRUARY 13, 2006Manufacture and Supply Agreement • May 4th, 2006 • Vivus Inc • Surgical & medical instruments & apparatus
This first amendment and waiver (the “Amendment and Waiver”) to the Manufacture and Supply Agreement dated December 22, 2003 (the “Original Agreement”), by and between VIVUS, Inc., having a principal place of business at 1172 Castro Street, Mountain View, California 94040, United States of America (“VIVUS”), and NeraPharm spol., s.r.o., having a place of business at Ulice Prace 657, 277 11 Neratovice, Czech Republic (“NeraPharm”) (each, a “Party” and collectively, the “Parties”).
AMENDMENT No. 2 TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • March 7th, 2024 • Savara Inc • Pharmaceutical preparations
This Amendment No. 2 to the Manufacture and Supply Agreement (“Amendment No. 2”), dated December 13, 2023 (“Effective Date”), is entered into by and between Savara ApS, a Denmark private limited company having registered offices at c/o Lundgrens Advokatpartnerselskab, Tuborg Boulevard 12, 2900 Hellerup, Denmark (“Savara”) and GEMABIOTECH SAU, a corporation organized under the laws of Argentina, having registered offices at Fray Justo Sarmiento 2350 Edificio 2B Piso 5, Olivos, Province of Buenos Aires, Argentina (“GEMA”) (each referred herein by name, or individually, as a “Party” or collectively, as the “Parties”).
AMENDMENT NO. 1 TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 10th, 2012 • Codexis Inc • Industrial organic chemicals
This Amendment No. 1 (“Amendment”) is entered into as of March 9, 2012 (the “Amendment Effective Date”) by and between Codexis, Inc., a Delaware corporation with a principal place of business at 200 Penobscot Dr., Redwood City, CA 94063, and its affiliates (“Codexis”) and Lactosan GmbH & Co. KG, a corporation organized and existing under the laws of Austria with a place of business at Industriestrasse West 5, A-8605, Kapfenberg, Austria (“Company”).
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • November 27th, 2007 • Vermillion, Inc. • Laboratory analytical instruments • California
THIS MANUFACTURE AND SUPPLY AGREEMENT (the “Agreement”), dated November 13, 2006, is between BIO-RAD LABORATORIES, INC., a Delaware corporation with offices at 1000 Alfred Nobel Drive, Hercules, California 94547 (“BIO-RAD”) and CIPHERGEN BIOSYSTEMS, INC., a Delaware corporation with offices at 6611 Dumbarton Circle, Fremont, California 94555 (“CIPHERGEN”).
CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 10th, 2022 • Lannett Co Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”) is made this 3rd day of March, 2022, by and between CHARTWELL PHARMACEUTICALS CARMEL, LLC, a New York limited liability company, having an address of 77 Brenner Drive, Congers, NY 10920 (“Chartwell”), CHARTWELL PHARMACEUTICALS LLC, a Delaware limited liability company (“Chartwell Pharmaceuticals”), and LANNETT COMPANY, INC. and/or its Affiliates (as defined below), a Delaware corporation having an address of 1150 Northbrook Drive, Suite 155, Trevose, PA 19053, USA (“Lannett”). Lannett and Chartwell are separately referred to as “Party” or jointly as “Parties.”
First Amendment to the Manufacture and Supply Agreement dated December 16, 2013Manufacture and Supply Agreement • November 3rd, 2015 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment to Manufacture and Supply Agreement (this “Amendment”) entered into as of 17 July, 2015 (the “Effective Date”) between AcelRx Pharmaceuticals, Inc., a company organized under the laws of the State of Delaware, United States (“AcelRx”), and having a principal place of business at 351 Galveston Drive, Redwood City, CA 94063, United States, and Grünenthal GmbH, a company organized under the laws of Germany (“Grünenthal”), having its registered office at Zieglerstrasse 6, 52078 Aachen, Germany.
MANUFACTURE AND SUPPLY AGREEMENT BETWEEN DRAXIS PHARMA, A division of DRAXIS SPECIALTY PHARMACEUTICALS INC. AND JOHNSON & JOHNSON CONSUMER COMPANIES, INC. AS OF SEPTEMBER 4, 2007Manufacture and Supply Agreement • March 31st, 2008 • Draxis Health Inc /Cn/ • Pharmaceutical preparations
This Manufacturing and Supply Agreement (the “Agreement”), is entered into as of September 4, 2007 (the “Effective Date”), by and between Johnson & Johnson Consumer Companies, Inc., a New Jersey corporation (“Buyer”), and DRAXIS Pharma, a division of DRAXIS Specialty Pharmaceuticals Inc., a Canadian corporation (“Manufacturer”). Buyer and Manufacturer are each a “Party” and are collectively, the “Parties”.
MANUFACTURE AND SUPPLY AGREEMENT by and between HYPERFINE RESEARCH, INC. and BENCHMARK ELECTRONICS, INC.Manufacture and Supply Agreement • August 30th, 2021 • HealthCor Catalio Acquisition Corp. • X-ray apparatus & tubes & related irradiation apparatus • New York
This Manufacture and Supply Agreement (this “Agreement”), effective as of October 15, 2018 (the “Effective Date”), is by and between HYPERFINE RESEARCH, INC., a Delaware corporation having a place of business at 530 Old Whitfield Street, Guilford, Connecticut 06437, for itself and its Affiliates (“Hyperfine”), and BENCHMARK ELECTRONICS, INC., a corporation organized under the laws of the State of Texas USA having a place of business at 100 Innovative Way, Nashua, NH 03062 (“Manufacturer”). Hyperfine and Manufacturer may be referred to individually as a “Party” and collectively as the “Parties.”
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • August 10th, 2010 • Neoprobe Corp • Surgical & medical instruments & apparatus • Missouri
THIS MANUFACTURE AND SUPPLY AGREEMENT is entered into this 30th day of November 2009, by and between Reliable Biopharmaceutical Corporation, a corporation organized under the laws of the State of Missouri, with its principal offices located at 1945 Walton Road, St. Louis, Missouri 63114 ("RELIABLE") and Neoprobe Corporation, a corporation organized under the laws of the State of Delaware, with offices located at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1367 ("NEOPROBE").
CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • February 27th, 2024 • SI-BONE, Inc. • Surgical & medical instruments & apparatus • New York
THIS MANUFACTURE AND SUPPLY AGREEMENT (“Agreement”) is entered into as of February 23, 2024 (the “Effective Date”), between SI-BONE, INC., a Delaware corporation having an address of 471 El Camino Real, Suite 101, Santa Clara, CA 95050 (“Company”) and RMS COMPANY, a Minnesota corporation having an address of 8600 Evergreen Boulevard, Coon Rapids, MN 55433 (“Supplier”).
AMENDMENT NO. 2 TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • May 20th, 2024 • OptiNose, Inc. • Pharmaceutical preparations
This AMENDMENT NO. 2 TO MANUFACTURE AND SUPPLY AGREEMENT (this “Amendment”) is effective as of this 20th day of May, 2024 (the “Amendment Effective Date”), and is entered into by and between OptiNose US, Inc., duly organized and existing under the laws of Delaware and having offices located at 1020 Stony Hill Road, Suite 300, Yardley, PA 19067 (referred to herein as “OptiNose”), and Contract Pharmaceuticals Limited Canada, duly organized under the laws of the Province of Ontario and having offices located at 7600 Danbro Crescent, Mississauga, Ontario Canada L5N 6L6 (referred to herein as “CPL”). OptiNose and CPL are each a “Party” and together constitute the “Parties” under this Agreement.
MANUFACTURE AND SUPPLY AGREEMENT Between BIOVECTRA INC. And KERYX BIOPHARMACEUTICALS, INC.Manufacture and Supply Agreement • March 26th, 2019 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This manufacture and supply agreement (“Agreement”) is made and entered into on May 26, 2017 by and between BioVectra Inc., with its registered offices at 11 Aviation Avenue, Charlottetown, PEI, C1E 0A1, Canada (“BioVectra”) and Keryx Biopharmaceuticals, Inc., with its offices at One Marina Park Drive, 12th floor, Boston, Massachusetts, USA, 02210 (“Keryx”).
AMENDMENT NO. 1 TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • November 27th, 2020 • Longview Acquisition Corp. • Blank checks
This Amendment No. 1 to Manufacture and Supply Agreement (this “Amendment”) is entered into effective as of August 2, 2019 (the “Amendment Effective Date”) by and between BUTTERFLY NETWORK, INC., a Delaware corporation (“Butterfly”) and BENCHMARK ELECTRONICS, INC., a Texas corporation and BENCHMARK ELECTRONICS (THAILAND) PCL, a Thailand public limited company (“Manufacturer”), to amend the Manufacture and Supply Agreement between Butterfly and Manufacturer effective as of October 1, 2015 (the “Agreement”). Butterfly and Manufacturer are each a “Party” and collectively the “Parties”. The capitalized terms herein shall have the meaning ascribed to them in the Agreement unless stated otherwise.
AMENDMENT No. 1 TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • March 30th, 2023 • Savara Inc • Pharmaceutical preparations
This Amendment No. 1 to the Manufacture and Supply Agreement (“Amendment No. 1”), dated December 7, 2022 (“Effective Date”), is entered into by and between Savara ApS, a Denmark private limited company having a principal place of business at c/o Lundgrens Advokatpartnerselskab, Tuborg Boulevard 12, 2900 Hellerup, Denmark (“Savara”) and GEMABIOTECH SAU, a corporation organized under the laws of Argentina, having a principal place of business at Avenida del Libertador 2740, Olivos, Province of Buenos Aires, Argentina (“GEMA”) (each referred herein by name, or individually, as a “Party” or collectively, as the “Parties”).
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • June 4th, 2024 • ThermoGenesis Holdings, Inc. • Laboratory apparatus & furniture • California
THIS MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”), is made as of May 29, 2024 (the “Effective Date”), by and between ThermoGenesis Corp., (a Delaware corporation) having its principal place of business at 2711 Citrus Road, Rancho Cordova, CA 95742 ("Thermo"), and Cord Blood Registry, a Delaware corporation having its principal place of business at 11915 La Grange Ave., Los Angeles, CA 90025 ("CBR").
MANUFACTURE AND SUPPLY AGREEMENT by and between HYPERFINE RESEARCH, INC. and BENCHMARK ELECTRONICS, INC.Manufacture and Supply Agreement • July 19th, 2021 • HealthCor Catalio Acquisition Corp. • Blank checks • New York
[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • July 10th, 2013 • Enzymotec Ltd. • Medicinal chemicals & botanical products
This Manufacture and Supply Agreement is made and entered into as of the 15 day of February, 2009 (the "Effective Date"), by and between Enzymotec Ltd., an Israeli company (“Enzymotec”) and PUNJAB Chemicals and Corp Protection Ltd., an Indian company (“Manufacturer”). Enzymotec and Manufacturer are sometimes herein referred to individually as a “party” and collectively the “parties”.
EXHIBIT 10.10.(b) FIRST AMENDMENT TO MANUFACTURE AND SUPPLY AGREEMENT between ALLERGAN SALES, INC. and CARL ZEISS, INC. on behalf of HUMPHREY SYSTEMS DIVISION Confidential treatment has been requested for portions of this exhibit. The copy filed...Manufacture and Supply Agreement • May 6th, 2002 • Advanced Medical Optics Inc • Wholesale-professional & commercial equipment & supplies
ADDENDUM TO MANUFACTURE AND SUPPLY AGREEMENTManufacture and Supply Agreement • March 5th, 2021
This announcement is made by Tian Chang Group Holdings Ltd. (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and the inside information provision (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Cap. 571).
